{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:22:55Z","timestamp":1785882175602,"version":"3.56.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      While several advances have been made in the last decade, reliable biomarkers for disease activity, prognosis, and response to treatment of rheumatoid arthritis (RA) have yet to be identified. In previous studies,\n                      <jats:italic>DUSP22<\/jats:italic>\n                      DNA methylation changes were found to be associated with RA and erosive disease. We conducted a pilot study to investigate plasma cell-free DNA (cfDNA) methylation in\n                      <jats:italic>DUSP22<\/jats:italic>\n                      in a cohort of RA patients and healthy controls. We also investigate\n                      <jats:italic>DUSP22<\/jats:italic>\n                      DNA methylation associations with RA clinical characteristics and treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      DNA was isolated from plasma from 27 RA patients who satisfied the ACR criteria, and 18 healthy controls.\n                      <jats:italic>DUSP22<\/jats:italic>\n                      DNA methylation was determined by pyrosequencing. Statistical analysis identified group differences and associations with RA clinical measures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      RA patients had lower cfDNA\n                      <jats:italic>DUSP22<\/jats:italic>\n                      DNA methylation at one specific DNA methylation site in the promoter region when compared to controls (36.7 \u00b1 3.3% for RA versus 46.9 \u00b1 2.6% for controls, age-adjusted-\n                      <jats:italic>p<\/jats:italic>\n                      = 0.049). For RA patients, age was associated with a significant decrease in\n                      <jats:italic>DUSP22<\/jats:italic>\n                      DNA methylation for all sites and the promoter region (\u03b2\n                      <jats:sub>\n                        <jats:italic>mean<\/jats:italic>\n                      <\/jats:sub>\n                      = \u22120.64,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.02). Lower DNA methylation was also associated with increased joint space narrowing (\u03c1\n                      <jats:sub>\n                        <jats:italic>CpGMean<\/jats:italic>\n                      <\/jats:sub>\n                      = \u22120.40,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our pilot study is the first to evaluate cfDNA methylation association to RA clinical characteristics. These exploratory findings suggest that\n                      <jats:italic>DUSP22<\/jats:italic>\n                      cfDNA methylation may represent a promising non-invasive biomarker in rheumatoid arthritis, a hypothesis that warrants validation in larger and ethnically diverse populations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1730527","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:30:23Z","timestamp":1770100223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual Specificity Phosphatase (DUSP22) promoter hypomethylation in cell-free DNA is associated with rheumatoid arthritis and its radiographic severity"],"prefix":"10.3389","volume":"13","author":[{"given":"Lissette","family":"Delgado-Cruzata","sequence":"first","affiliation":[{"name":"John Jay College of Criminal Justice, City University of New York","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Rodriguez","family":"Alvarez","sequence":"additional","affiliation":[{"name":"State University of New York Downstate Medical Center","place":["Brooklyn, NY, United States"]},{"name":"Boehringer Ingelheim Pharmaceuticals","place":["Ridgefield, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alorah D.","family":"Bliese","sequence":"additional","affiliation":[{"name":"John Jay College of Criminal Justice, City University of New York","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni-Ann T.","family":"Bravo","sequence":"additional","affiliation":[{"name":"John Jay College of Criminal Justice, City University of New York","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Petraco","sequence":"additional","affiliation":[{"name":"John Jay College of Criminal Justice, City University of New York","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Guzman","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals, Lincoln Medical Center","place":["Bronx, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallis","family":"Tavarez","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals, Lincoln Medical Center","place":["Bronx, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menachem","family":"Gold","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals, Lincoln Medical Center","place":["Bronx, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shante","family":"Hinson","sequence":"additional","affiliation":[{"name":"New York City Health + Hospitals, Lincoln Medical Center","place":["Bronx, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/intimm\/dxr077","article-title":"IL-1\u03b2 and TNF\u03b1-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.","volume":"23","author":"Mori","year":"2011","journal-title":"Int Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1053\/berh.2002.0257","article-title":"Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome.","volume":"16","author":"Symmons","year":"2002","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/eji.201444453","article-title":"A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells.","volume":"44","author":"Kennedy","year":"2014","journal-title":"Eur J Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.4161\/epi.29718","article-title":"Genome-wide DNA methylation profiling in rheumatoid arthritis identifies disease-associated methylation changes that are distinct to individual T- and B-lymphocyte populations.","volume":"9","author":"Glossop","year":"2014","journal-title":"Epigenetics."},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2217\/epi.15.103","article-title":"Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T and B lymphocytes.","volume":"8","author":"Glossop","year":"2016","journal-title":"Epigenomics."},{"key":"B6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13073-016-0374-0","article-title":"High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis.","volume":"8","author":"Gomez-Cabrero","year":"2016","journal-title":"Genome Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/epi-2016-0042","article-title":"DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis.","volume":"9","author":"Glossop","year":"2017","journal-title":"Epigenomics."},{"key":"B8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13075-017-1276-2","article-title":"DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis.","volume":"19","author":"Meng","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/art.40408","article-title":"Hypomethylation of CYP2E1 and DUSP22 promoters associated with disease activity and erosive disease among rheumatoid arthritis patients.","volume":"70","author":"Mok","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/art.39952","article-title":"Rheumatoid arthritis naive T cells share hypermethylation sites with synoviocytes.","volume":"69","author":"Rhead","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1042\/BST20130053","article-title":"The role of histone deacetylases in rheumatoid arthritis fibroblast-like synoviocytes.","volume":"41","author":"Hawtree","year":"2013","journal-title":"Biochem Soc Trans."},{"key":"B12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/annrheumdis-2012-201526","article-title":"DNA methylome signature in rheumatoid arthritis.","volume":"72","author":"Nakano","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jaut.2012.12.005","article-title":"Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression.","volume":"41","author":"de la Rica","year":"2013","journal-title":"J Autoimmun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1016-8478(23)13385-1","article-title":"The VH1-like dual-specificity protein tyrosine phosphatases.","volume":"8","author":"Martell","year":"1998","journal-title":"Mol Cells."},{"key":"B15","doi-asserted-by":"publisher","first-page":"36592","DOI":"10.1074\/jbc.M200453200","article-title":"The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway.","volume":"277","author":"Chen","year":"2002","journal-title":"J Biol Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1038\/sj.onc.1209578","article-title":"Regulation of STAT3-mediated signaling by LMW-DSP2.","volume":"25","author":"Sekine","year":"2006","journal-title":"Oncogene."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1038\/ncomms4618","article-title":"The phosphatase JKAP\/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck.","volume":"5","author":"Li","year":"2014","journal-title":"Nat Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0164259","DOI":"10.1371\/journal.pone.0164259","article-title":"Scaffold role of DUSP22 in ASK1-MKK7-JNK signaling pathway.","volume":"11","author":"Ju","year":"2016","journal-title":"PLoS One."},{"key":"B19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1177\/0961203311399606","article-title":"Increased levels of circulating DNA in patients with systemic autoimmune diseases: a possible marker of disease activity in Sj\u00f6gren\u2019s syndrome.","volume":"20","author":"Bartoloni","year":"2011","journal-title":"Lupus."},{"key":"B20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/08916930701356317","article-title":"Sensitive detection of plasma\/serum DNA in patients with systemic lupus erythematosus.","volume":"40","author":"Chen","year":"2007","journal-title":"Autoimmunity."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s10067-009-1245-5","article-title":"Cell-free DNA in the plasma of patients with systemic sclerosis.","volume":"28","author":"Mosca","year":"2009","journal-title":"Clin Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13075-017-1295-z","article-title":"Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.","volume":"19","author":"Rykova","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"R234","DOI":"10.1186\/ar787","article-title":"Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis.","volume":"5","author":"Hajizadeh","year":"2003","journal-title":"Arthritis Res Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1373\/clinchem.2006.084509","article-title":"Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis.","volume":"53","author":"Zhong","year":"2007","journal-title":"Clin Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1756-185X.12959","article-title":"Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis.","volume":"20","author":"Hashimoto","year":"2017","journal-title":"Int J Rheum Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/european league against rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.berh.2007.02.004","article-title":"The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care.","volume":"4","author":"Aletaha","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0003-4967(24)43379-7","article-title":"Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages.","volume":"60","author":"Boini","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/rheumatology\/38.10.941","article-title":"Reliability and sensitivity to change of a simplification of the Sharp\/van der Heijde radiological assessment in rheumatoid arthritis.","volume":"38","author":"van der Heijde","year":"1999","journal-title":"Rheumatology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1537934","DOI":"10.3389\/fphar.2025.1537934","article-title":"Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders.","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.39031","article-title":"Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis.","volume":"67","author":"Cribbs","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/epi.15.15","article-title":"DNA methylation profiling of synovial fluid FLS in rheumatoid arthritis reveals changes common with tissue-derived FLS.","volume":"7","author":"Glossop","year":"2015","journal-title":"Epigenomics."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.4049\/jimmunol.1202572","article-title":"Regulation of DNA methylation in rheumatoid arthritis synoviocytes.","volume":"190","author":"Nakano","year":"2013","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fimmu.2020.00662","article-title":"Identification of specific joint-inflammatogenic cell-free DNA molecules from synovial fluids of patients with rheumatoid arthritis.","volume":"11","author":"Dong","year":"2020","journal-title":"Front Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/1874312901206010220","article-title":"c-Jun N-terminal kinase in inflammation and rheumatic diseases.","volume":"6","author":"Guma","year":"2012","journal-title":"Open Rheumatol J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00199","DOI":"10.1042\/BSR20140141","article-title":"MAPK\/JNK signalling: a potential autophagy regulation pathway.","volume":"35","author":"Zhou","year":"2015","journal-title":"Biosci Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3389\/fimmu.2018.01577","article-title":"Autophagy and rheumatoid arthritis: current knowledges and future perspectives.","volume":"9","author":"Vomero","year":"2018","journal-title":"Front Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"7623145","DOI":"10.1155\/2017\/7623145","article-title":"The autophagy level is increased in the synovial tissues of patients with active rheumatoid arthritis and is correlated with disease severity.","volume":"2017","author":"Zhu","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/cei\/uxad064","article-title":"Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.","volume":"213","author":"Hashimoto","year":"2023","journal-title":"Clin Exp Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/hmg\/ddt511","article-title":"A methylome-wide study of aging using massively parallel sequencing of the methyl-CpG-enriched genomic fraction from blood in over 700 subjects.","volume":"23","author":"McClay","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/hmg\/ddt531","article-title":"Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites.","volume":"23","author":"Florath","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-017-0947-x","article-title":"Selective suppression of the JNK-MMP2\/9 signal pathway by tetramethylpyrazine attenuates neuropathic pain in rats.","volume":"14","author":"Jiang","year":"2017","journal-title":"J Neuroinflammation."},{"key":"B43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00296-018-04235-y","article-title":"Secular trends in the incidence and prevalence of rheumatoid arthritis within members of an integrated health care delivery system.","volume":"39","author":"Kawatkar","year":"2019","journal-title":"Rheumatol Int."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.amjmed.2013.09.002","article-title":"Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.","volume":"126","author":"Greenberg","year":"2013","journal-title":"Am J Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/gepi.21938","article-title":"Genetic variants influencing joint damage in Mexican Americans and European Americans with rheumatoid arthritis.","volume":"39","author":"Arya","year":"2015","journal-title":"Genet Epidemiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/art.11000","article-title":"Ethnic variation in the clinical manifestations of rheumatoid arthritis: role of HLA-DRB1 alleles.","volume":"49","author":"Del Rinc\u00f3n","year":"2003","journal-title":"Arthritis Rheum."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1730527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T06:30:24Z","timestamp":1770100224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1730527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":46,"alternative-id":["10.3389\/fmed.2026.1730527"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1730527","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"article-number":"1730527"}}